Stocks · Health care · Pharmaceutical Preparations

Opus Genetics, Inc.

IRD Clue Score33
United States Fiscal year ends December CIK 0001228627 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert E. Gagnon
23 Oct 2026
Chief Financial Officer
Sold on a plan
14,000
$3.55
$49.65K

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 23
Transactions with no price 6
Shares from compensation/vesting 18,098,737
History held since 8 Jan 2007